Proopiomelanocortin is a polypeptide precursor molecule, the processing of which generates ACTH, ji-endorphin, the f-and
Introduction
ACTH derives from the posttranslational processing of proopiomelanocortin (POMC),' a complex polypeptide precursor molecule (1) (2) (3) . In most mammalian species a single functional gene per haploid genome encodes POMC (4) (5) (6) (7) (8) (9) . Two different cell types within the pituitary gland have long been recognized as the major sites of POMC gene expression; the 1 . Abbreviations used in this paper: f end, f endorphin; CLIP, corticotropin-like intermediary lobe peptide; h, human; LPH, lipotropin; MSH, melanocyte-stimulating hormone; NT, NH2-terminal; nt, nucleotide; POMC, proopiomelanocortin.
anterior lobe corticotrophs and the intermediate lobe melanotrophs both contain high concentrations of a 1,100-l,200-nucleotide (nt) POMC mRNA (10) (11) (12) (13) (14) . The coordinate proteolysis or processing of the generated POMC molecule produces various peptide fragments: an NH2-terminal fragment (NT), joining peptide, ACTH, f3-lipotropin (flLPH), and a small but definite amount of y-LPH and f3-endorphin (I#end) are formed in the anterior lobe of the pituitary (15) (16) (17) (18) (19) ; in the intermediate lobe, smaller peptides are released such as ,B-melanocytestimulating hormone (plMSH), corticotropin-like intermediary lobe peptide (CLIP) , and aMSH (20, 21) . Thus the anterior pituitary corticotrophs appear as the predominant, if not the sole source of circulating ACTH. Recently it has become clear that POMC peptides were normally present in extracts of many nonpituitary tissues such as the brain, the gastrointestinal tract, the adrenal medulla, the placenta, and the female and male gonads (22) . One of the most extensively studied tissue is the testis. Immunocytochemical and in situ hybridization techniques have shown the presence of both POMC peptides and RNA within the Leydig cell (23, 24) . These studies also revealed two unexpected findings: (a) the testis POMC RNA is shorter than the pituitary POMC mRNA, being -800 nt long (25, 26) . We (38) . Contrary to the previous RIA, h(3LPH and hI3MSH showed 100% cross-reactivity, and hflMSH5-22 had no cross-reactivity.
The hrend RIA was performed as described (39) 
Results
Analysis ofPOMC transcripts. RNA from eight normal testes were examined by blot hybridization with the pHOX 3A probe (Fig. 1) . Variable amounts of a highly predominant RNA species were detected in all samples, demonstrating that POMC gene expression is a constant feature ofthis tissue. Comparison with normal human pituitary (Fig. 1, lane P) indicated that this signal corresponded to the previously characterized 800-nt POMC RNAs. The same probe was used to examine RNAs extracted from six human Leydig cell tumors (Fig. 2) ; whereas the 800-nt mRNA was similarly present, a second signal identical to the 1,200-nt pituitary mRNA could be detected in five of the six tumors. RNA extracted from the adjacent, nontumoral region of three of the Leydig cell tumors only contained the 800-nt RNAs, as in normal testis (Fig. 3 A, lane T, and data not shown). Tumors 1 and 2, which contained the highest amounts of the 1,200-nt POMC, mRNA, were analyzed further with the pHOX 1 probe (Fig. 3 B) ; as expected, none of the 800-nt RNAs contained exon 1 sequences, whereas the 1,200-nt mRNAs were similarly hybridized whether they origi- crude desalted guanidine supernatant or tissue extract using a COOH-terminal hflend RIA, which recognized the unprocessed precursor as well (it was determined that the two different extraction methods gave the same results in other tumors). Whereas 3end immunoreactivity was barely detectable in extracts of 10 normal human testes, it was at least a thousand times higher in Leydig cell tumors 1 and 2, although still far from that in the pituitary, and significantly increased in tumor 3 ( Table I) .
The high content of POMC peptides in tumors 1 and 2 allowed a fine evaluation of the precursor processing. The combined use of Sephadex G-75 gel exclusion chromatography and RIA of the collected fractions with a battery of antisera, demonstrated the presence of peptides similar to Figure 5 . RP-HPLC of immunoreactive Leydig cell tumor ACTH. Fractions corresponding to the immunoreactive z ACTH peak (Fig. 4 a) were Iyophilized and sub- (40) . The translation efficiency of the short RNAs has been questioned since POMC peptides in the normal testis are extremely low for the amount of transcripts (29); we have postulated that the small amounts of POMC peptides, which can actually be detected in the normal testis, are not generated from the translation of the short RNAs, but rather derive from a minor (< 1%) and barely detectable population of pituitary-like (1,200 nt) POMC tran- scripts which could only be demonstrated by the use of highly sensitive SI nuclease mapping with a uniformly labeled single strand DNA probe (27) . These Leydig cell tumors provided a unique opportunity to examine what consequence the appearance of large amounts of 1,200-nt POMC mRNA would have on the production of POMC peptides in a nonpituitary tissue.
As an overall estimate of the amount of POMC peptides, we chose a COOH-terminal #end RIA because it recognized the peptide fragment and the unprocessed precursor as well (41) . Whereas #end immunoreactivity was barely measurable in extracts of 10 normal human testes, it was at least 1,000-fold higher in the two Leydig cell tumors which contained the highest concentrations of the 1,200-nt POMC transcripts (Table I ). The fact that the tumor tissue contains an almost homogeneous population of Leydig cells should only account for at most a 33-fold increase since the normal human testis contains between 3 and 19% of Leydig cells (42) .
Although it had not been specifically searched for by the usual laboratory investigations, a Cushing's syndrome apparently was not present in the two patients whose tumors contained high concentrations of POMC peptides. These tissue concentrations however remained far (-1,000-fold lower) from that in the normal and tumoral pituitaries (43) . The exceptional cases of Cushing's syndrome associated with Leydig cell tumors resulted from the local secretion of cortisol (44) .
Another crucial event in the overall mechanism of POMC gene expression is the post-translational processing of POMC which determines whether ACTH itself is produced and eventually secreted. Altered modes of POMC processing have been described in human ACTH-producing nonpituitary tumors, where it can either be absent (41, 45) Recently, various peptide hormones, and in some cases their mRNA, have been identified in cell types which were thought (up to now) to produce only steroid hormones; inhibin in the granulosa cells (46) and prorenin in the theca cells of the human ovary (47) are two examples. In the Leydig cell itself, renin (48), enkephalin (49) , activin (50) , and AVP (51) are other recent examples. The presence of AVP, as fully characterized by HPLC, is a further demonstration that polypeptide precursor processing can occur in the testis, also stressing the fact that processing enzymes may have a wide tissue distribution, although they are not present in all cell types (52) .
The presence of secretory granules and their biochemical markers, the chromogranins, have been stressed as the specific hallmark of neuro-endocrine or peptide hormone secreting cells to discriminate them from other endocrine cells which produce steroid or thyroid hormones (53, 54) . These secretory granules are also associated with a specific secretory mechanism called the regulatory pathway (55) . It is now clear that peptide hormones may be secreted by steroid producing cells (50) , of which the well known peptide secretions of the placenta is the best example (56 (27) . It Our results show that in a tissue which normally expresses the POMC gene predominantly as a short, truncated RNA, activation of a pituitary promoter may induce a dramatic rise in the production of POMC peptides. We suggest that this phenomenon is occasionally caused by, or associated with, tumor transformation and is the first and mandatory step for the production of large amounts of POMC fragments such as ACTH.
